Publication | Open Access

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

Srd5a2 PolymorphismAndrogen-deprivation TherapyAndrologyUrologyGenitourinary CancerMedicineProstatic DiseaseEndocrinologyOncologyRadiation OncologySerum TestosteroneEndocrine-related Cancer